Erste Asset Management’s Vir Biotechnology VIR Stock Holding History

Erste Asset Management’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Hold	180,800	–	–	0.01%	386
2026 Q1	$1.53M	Buy	180,800 +152,000	+528%	+$1.21M	0.01%	399
2025 Q4	$172K	Hold	28,800	–	–	﹤0.01%	554
2025 Q3	$162K	Hold	28,800	–	–	﹤0.01%	564
2025 Q2	$149K	Hold	28,800	–	–	﹤0.01%	792
2025 Q1	$193K	Hold	28,800	–	–	﹤0.01%	473
2024 Q4	$215K	Hold	28,800	–	–	﹤0.01%	483
2024 Q3	$217K	Hold	28,800	–	–	﹤0.01%	477
2024 Q2	$255K	Hold	28,800	–	–	﹤0.01%	463
2024 Q1	$291K	Hold	28,800	–	–	﹤0.01%	463
2023 Q4	$296K	Hold	28,800	–	–	﹤0.01%	462
2023 Q3	$265K	Hold	28,800	–	–	﹤0.01%	462
2023 Q2	$719K	Hold	28,800	–	–	0.01%	386
2023 Q1	$662K	Hold	28,800	–	–	0.01%	401
2022 Q4	$723K	Hold	28,800	–	–	0.02%	394
2022 Q3	$550K	Hold	28,800	–	–	0.01%	411
2022 Q2	$749K	Hold	28,800	–	–	0.02%	390
2022 Q1	$746K	Sell	28,800 -4,500	-14%	-$133K	0.01%	386
2021 Q4	$1.3M	Hold	33,300	–	–	0.02%	333
2021 Q3	$1.44M	Hold	33,300	–	–	0.03%	306
2021 Q2	$1.55M	Hold	33,300	–	–	0.03%	311
2021 Q1	$1.59M	Hold	33,300	–	–	0.04%	296
2020 Q4	$952K	Buy	+33,300	New	+$1.08M	0.03%	341

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Erste Asset Management's VIR Position: Q2 2026 in Review

Erste Asset Management held its Vir Biotechnology (VIR) position steady in Q2 2026 at 180,800 shares worth $1.88M. The position accounts for 0.01% of the portfolio, ranked #386.

Erste Asset Management first reported a position in VIR in Q4 2020 and has held it in 23 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Erste Asset Management held 180,800 shares of Vir Biotechnology worth $1.88M as of Q2 2026.
Erste Asset Management left its Vir Biotechnology share count unchanged in Q2 2026.
Vir Biotechnology made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #386 holding.
Erste Asset Management first reported a position in Vir Biotechnology in Q4 2020 and has held it in 23 quarters since.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.